Form DEL AM - Delaying amendment
10 Octubre 2024 - 9:37AM
Edgar (US Regulatory)
DEL
AM
October
10, 2024
VIA
EDGAR
U.S.
Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, NE
Washington,
D.C. 20549
|
RE: |
Ensysce
Biosciences, Inc. |
|
|
Registration
Statement on Form S-3 |
|
|
File
No. 333-282563 |
To
Whom It May Concern:
Reference
is made to the Registration Statement on Form S-3 (File No. 333-282563) filed by Ensysce Biosciences, Inc. (the “Company”)
with the Securities and Exchange Commission on October 9, 2024 (the “Registration Statement”). Pursuant to Rule 473(a) of
the Securities Act of 1933, as amended (the “Securities Act”), the following delaying amendment, prescribed by Rule 473(a)
of the Securities Act, is hereby incorporated into the facing page of the Registration Statement:
The
registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the
registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective
in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date
as the Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.
Thank
you.
Sincerely,
/s/ Dr. Lynn
Kirkpatrick |
|
Dr. Lynn Kirkpatrick |
|
President, Chief Executive Officer and Director |
|
Ensysce Biosciences Inc ... (PK) (USOTC:ENSCW)
Gráfica de Acción Histórica
De Sep 2024 a Oct 2024
Ensysce Biosciences Inc ... (PK) (USOTC:ENSCW)
Gráfica de Acción Histórica
De Oct 2023 a Oct 2024
Real-Time news about Ensysce Biosciences Inc Warrant (PK) (OTCMarkets): 0 recent articles
Más de Ensysce Biosciences Inc Warrant (PK) Artículos de Noticias